Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
C4 THERAPEUTICS, INC. | Delayed Nasdaq 04:00:00 2023-09-22 pm EDT |
|
5-day change | 1st Jan Change | |
| 2.040 USD | -6.85% | -8.52% | -65.42% | |
| Sep. 18 | ImmunoGen Names Lauren White CFO | MT |
| Sep. 06 | C4 Therapeutics Appoints Kendra Adams as Finance Chief | MT |
Chart calendar C4 Therapeutics, Inc.
b240395c1bde.ay9XKx7dqeVIEnli46mnciCZX4b_sbcKRpJ8br7gfj0.PB42e3Ds3IZ7YkpUrtqKPnX9L-nOxdoyI_cuHOyEC0ofaxxZeY7unDxWQQ~497348055cf4073fa026828499d1e196
Upcoming events on C4 Therapeutics, Inc.
Past events on C4 Therapeutics, Inc.
| 2023-08-08 07:00 am | Q2 2023 Earnings Release |
| 2023-06-14 | Annual General Meeting |
| 2023-06-06 | Jefferies Global Healthcare Conference |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference |
| 2023-05-04 07:00 am | Q1 2023 Earnings Release |
| 2023-04-26 11:00 am | Stifel Targeted Oncology Days |
| 2023-03-05 | Cowen Health Care Conference |
| 2023-02-23 07:00 am | FY 2022 Earnings Release |
| 2023-02-21 12:00 pm | Wells Fargo Targeted Protein Degradation (TPD) Virtual Summit - Panel |
| 2023-02-15 03:00 pm | SVB Securities Global Biopharma Conference |
| 2023-01-09 01:30 pm | JP Morgan Healthcare Conference |
| 2022-12-01 09:15 am | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2022-11-16 | Connective Tissue Oncology Society Meeting |
| 2022-11-08 05:00 pm | Credit Suisse Healthcare Conference - Fireside Chat |
| 2022-11-03 07:00 am | Q3 2022 Earnings Release |
| 2022-10-24 | Targeted Protein Degradation Summit |
| 2022-10-16 | Discovery on Target Coference |
| 2022-10-03 09:50 am | Bank of America Precision Oncology Conference |
| 2022-09-06 | Wells Fargo Healthcare Conference |
| 2022-08-04 08:00 am | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21,4 | 33,2 32,9 0.85% | 45,8 33,1 38.4% | 31,1 39,8 -21.86% | 18,6 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -55,4 -59,5 6.94% | -59,1 -88,3 33.07% | -97,8 -88,9 -10.12% | -120 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -60,4 -62,2 2.83% | -82,1 -94,0 12.63% | -130 -112 -15.31% | -144 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -67,0 -63,6 -5.28% | -83,9 -98,5 14.79% | -128 -127 -0.91% | -147 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -66,3 -72,0 7.91% | -83,9 -98,2 14.59% | -128 -125 -2.38% | -148 |
|
EPS USD | Released Forecast Spread | -3,67 | -1,54 -2,54 39.39% | -1,82 -2,09 13.05% | -2,62 -2,49 -5.11% | -2,74 |
| Announcement Date | 09/10/20 | 03/11/21 | 02/24/22 | 02/23/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,78 6,62 47.83% | 8,50 7,81 8.89% | 20,1 7,70 160.82% | 7,65 8,05 -4.91% | 13,8 8,51 62.61% | 6,75 9,26 -27.08% | 2,85 10,9 -73.92% | 3,76 5,46 -31.19% | 2,66 6,44 -58.63% | 5,46 | 4,10 | |||
|
EBITDA Million USD | Released Forecast Spread | -21,6 -21,3 -1.07% | -23,9 -27,9 14.25% | -8,58 -22,8 62.33% | -31,1 -18,6 -66.61% | -26,9 -19,0 -41.97% | -32,1 -20,4 -57.07% | -30,9 -10,4 -195.58% | -35,7 -26,8 -33.23% | -30,7 -23,5 -30.77% | -28,5 | -33,8 | |||
|
EBIT Million USD | Released Forecast Spread | -22,1 -22,1 -0.04% | -24,3 -26,8 9.34% | -15,3 -27,2 43.98% | -31,4 -27,7 -13.41% | -27,4 -30,7 10.92% | -32,5 -29,9 -8.79% | -38,3 -28,0 -36.55% | -36,2 -36,6 1.05% | -37,6 -35,3 -6.56% | -36,4 | -40,2 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,7 -28,1 12.2% | -15,7 -30,2 48.15% | -31,6 -30,5 -3.63% | -27,4 -34,8 21.18% | -32,0 -32,8 2.64% | -37,2 -36,0 -3.24% | -34,8 -37,1 6.32% | -35,9 -36,2 0.72% | -38,1 | -40,0 | ||||
|
Net income Million USD | Released Forecast Spread | -22,6 -25,0 9.7% | -24,7 -28,7 13.88% | -15,7 -28,0 44.07% | -31,6 -29,5 -7.31% | -27,4 -33,1 17.08% | -32,0 -33,3 3.95% | -37,2 -33,7 -10.43% | -34,8 -37,9 8.17% | -35,9 -36,8 2.36% | -36,8 | -40,7 | |||
|
EPS USD | Released Forecast Spread | -0,51 -0,56 8.11% | -0,51 -0,59 13.8% | -0,31 -0,57 45.89% | -0,65 -0,59 -10.29% | -0,56 -0,65 14.32% | -0,65 -0,67 3.69% | -0,76 -0,67 -14.02% | -0,71 -0,77 7.66% | -0,73 -0,75 2.54% | -0,69 | -0,67 | -0,38 | -0,39 | -0,31 |
| Announcement Date | 08/11/21 | 11/10/21 | 02/24/22 | 05/05/22 | 08/04/22 | 11/03/22 | 02/23/23 | 05/04/23 | 08/08/23 | - | - | - | - | - |
More events
Past sector events for C4 Therapeutics, Inc.
| 2023-09-21 12:00 pm | ABIVAX SOCIÉTÉ ANONYME : Q2 2023 Earnings Release |
| 2023-09-21 01:00 am | VALNEVA SE : Q2 2023 Earnings Release |
| 2023-09-07 02:00 am | GENUS PLC : Q4 2023 Earnings Release |
| 2023-08-30 | BIDE PHARMATECH CO. : Q2 2023 Earnings Release |
| 2023-08-30 | GEMPHARMATECH CO. : Q2 2023 Earnings Release |
| 2023-08-30 | HINOVA PHARMACEUTICALS INC. : Q2 2023 Earnings Release |
| 2023-08-30 04:15 pm | ALVOTECH : Q2 2023 Earnings Release |
| 2023-08-29 | FORMYCON AG : Q2 2023 Earnings Release |
| 2023-08-29 | JOINN LABORATORIES(CHINA)CO. : Q2 2023 Earnings Release |
| 2023-08-29 02:00 am | PURETECH HEALTH PLC : Q2 2023 Earnings Release |
